首页> 外文期刊>Research in Microbiology >Attenuated Listeria monocytogenes, a Mycobacterium tuberculosis ESAT-6 antigen expression and delivery vector for inducing an immune response
【24h】

Attenuated Listeria monocytogenes, a Mycobacterium tuberculosis ESAT-6 antigen expression and delivery vector for inducing an immune response

机译:减毒单核细胞增生李斯特菌,一种结核分枝杆菌ESAT-6抗原表达和递送载体,用于诱导免疫应答

获取原文
获取原文并翻译 | 示例
           

摘要

We selectively expressed protective Mycobacterium tuberculosis antigen ESAT-6 in recombinant strains Lm(esat-6) and LmΔactA/plcB(esat-6) to evaluate the capacity of Listeria monocytogenes to deliver antigens from M. tuberculosis, and we studied the pathogenicity and immunogenicity of these strains compared with virulent parental strain yzuLm4 and attenuated strain LmΔactA/plcB. The two recombinant strains retained listeriolysin O hemolytic activity, escaped into the cytosol niche and established replication in the macrophage-like RAW264.7 cell line; however, these strains showed decreased virulence in C57BL/6 mice. Histopathology revealed no obvious pathological changes following administration of the recombinant strains to mice, indicating that they were significantly safer than parental strains. Moreover, intravenous vaccination of mice with the recombinant strains elicited specific Th1-type cellular immunity, splenocyte proliferation and effective CTL activity in vivo. Thus, attenuated L. monocytogenes strains can be used as effective vectors for delivering M. tuberculosis ESAT-6 and inducing a cellular immune response, suggesting that such vectors may be effective as novel vaccines for preventing tuberculosis.
机译:我们在重组菌株Lm(esat-6)和LmΔactA/ plcB(esat-6)中选择性表达了保护性结核分枝杆菌抗原ESAT-6,以评估单核细胞增生李斯特菌从结核分枝杆菌中传递抗原的能力,并研究了其致病性和免疫原性这些菌株与有毒的亲本菌株yzuLm4和减毒菌株LmΔactA/ plcB相比。这两个重组菌株保留了李斯特菌溶血素O的溶血活性,逃逸到胞浆中,并在巨噬细胞样RAW264.7细胞系中建立了复制。但是,这些菌株在C57BL / 6小鼠中显示出降低的毒力。在向小鼠施用重组菌株后,组织病理学没有显示出明显的病理变化,表明它们比亲本菌株安全得多。此外,用重组株对小鼠进行静脉内疫苗接种可引起体内特异性的Th1型细胞免疫,脾细胞增殖和有效的CTL活性。因此,减毒的单核细胞增生李斯特氏菌菌株可以用作递送结核分枝杆菌ESAT-6和诱导细胞免疫应答的有效载体,表明这种载体可以作为预防结核病的新型疫苗有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号